Table 2. Univariate and multivariate analyses of overall survival in patients with HCC.
Covariate | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
χ2 | P-value | HR | (95% CI) | P-value | ||
Age | 1.600 | 0.206 | 1.321 | 0.384 | 3.989 | 0.721 |
Gender | 1.165 | 0.280 | 1.645 | 0.381 | 5.542 | 0.285 |
Race | 0.990 | 0.320 | 1.725 | 0.426 | 5.892 | 0.361 |
AFP | 0.093 | 0.761 | 0.895 | 0.325 | 2.462 | 0.829 |
Cirrhosis | 1.080 | 0.299 | 1.895 | 0.578 | 6.200 | 0. 291 |
Tumor size | 28.902 | <0.001* | 0.135 | 0.042 | 0.052 | <0.001* |
Lymph node metastasis | 0.163 | 0.686 | 0.285 | 0.426 | 1.892 | 0.648 |
Distant metastasis | 4.031 | 0.045* | 0.047 | 0.232 | 0.067 | 0.011* |
Differentiation grade | 0.192 | 0.661 | 0.296 | 0.431 | 1.910 | 0.653 |
Child–Pugh Grade | 8.018 | 0.005* | 1.103 | 0.061 | 0.461 | 0.015* |
Tumor stage | 24.084 | <0.001* | 0.723 | 0.057 | 1.201 | 0.061 |
miR-27a-3p | 6.088 | 0.014* | 1.117 | 0.013 | 0.291 | 0.010* |
P<0.05.